EUVIMEDEUVIMED entdecken
Crossref

Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer

Jie Li, Yao Wu, Yongping Li, Hongbo Zhu, Zhiwen Zhang iD, Yaping Li iD

ACS Nano · 01.10.2024 · 18 (39) · 26585-26599

DOI: 10.1021/acsnano.4c04322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 17.09.2024. Verfasst von Jie Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, …. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Glutathione, Receptors, Androgen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Pudong New Area Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTriple Negative Breast NeoplasmsGlutathioneReceptors, AndrogenAnimalsMiceHumansFemalePhospholipid Hydroperoxide Glutathione PeroxidaseAntineoplastic AgentsMice, Inbred BALB CCell ProliferationNanoparticlesCell Line, TumorDrug Screening Assays, AntitumorCarbolines

Stichwörter der Autor:innen

ferroptosisglutathioneglutathione peroxidase 4nanotherapeuticstriple-negative breast cancer

Substanzen

GlutathioneReceptors, AndrogenPhospholipid Hydroperoxide Glutathione PeroxidaseRSL3 compoundAntineoplastic AgentsCarbolines

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Pharmacy & Key Laboratory of Smart Drug Delivery (Ministry of Education), Fudan University, Shanghai 201203, China.
  • Department of Breast Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, Shandong, China.

ORCID-Profile: Zhiwen Zhang, Yaping Li

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Pudong New Area Health Commission

Zitieren

APA

Li, J., Wu, Y., Li, Y., Zhu, H., Zhang, Z., & Li, Y. (2024). Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. ACS Nano, 18(39), 26585-26599. https://doi.org/10.1021/acsnano.4c04322

Vancouver

Li J, Wu Y, Li Y, Zhu H, Zhang Z, Li Y. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. ACS Nano. 2024;18(39):26585-26599. doi:10.1021/acsnano.4c04322

BibTeX
@article{Li2024,
  author = {Li, Jie and Wu, Yao and Li, Yongping and Zhu, Hongbo and Zhang, Zhiwen and Li, Yaping},
  title = {Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {39},
  pages = {26585--26599},
  doi = {10.1021/acsnano.4c04322}
}
Kostenlos starten →